Benazeprilat
CAS: 86541-78-8
Ref. 3D-FB18161
1mg | 136.00 € | ||
2mg | 168.00 € | ||
5mg | 341.00 € | ||
10mg | 498.00 € | ||
25mg | 1,017.00 € |
Product Information
- (3S)-3-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid
- (2S)-2-{[(3S)-1-(Carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino}-4-phenylbutanoic acid
- (S-(R*,R*))-3-((1-Carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid
- 1H-1-Benzazepine-1-acetic acid, 3-[(1-carboxy-3-phenylpropyl)amino]-2,3,4,5-tetrahydro-2-oxo-, [S-(R*,R*)]-
- 1H-1-benzazepine-1-acetic acid, 3-[[(1S)-1-carboxy-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3S)-
- Benazeprilate
- Cgs 14831
Benazeprilat is a prodrug that is metabolized to enalaprilat, its active form. It is an inhibitor of angiotensin-converting enzyme (ACE) and has been shown to be effective in the treatment of heart failure. It has also been shown to inhibit ACE activity in vitro and in experimental models of congestive heart failure. Benazeprilat binds to the active site on the ACE molecule and inhibits the conversion of angiotensin I into angiotensin II, which causes vasoconstriction and stimulates aldosterone release from the adrenal cortex. This drug also has effects on energy metabolism by stimulating beta oxidation, which leads to increased levels of ketone bodies in blood plasma.
Chemical properties
Technical inquiry about: 3D-FB18161 Benazeprilat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.